S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
Free Trial
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

→ Chances are you know the firms on this list (From WealthPress) (Ad)
Free AMPE Stock Alerts
$0.40
+0.16 (+65.29%)
(As of 10:30 AM ET)
Compare
Today's Range
$0.35
▼
$0.40
50-Day Range
$0.24
▼
$2.30
52-Week Range
$0.14
▼
$8.30
Volume
4,507 shs
Average Volume
151,588 shs
Market Capitalization
$454,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media
AMPE stock logo

About Ampio Pharmaceuticals Stock (NYSE:AMPE)

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

AMPE Stock Price History

AMPE Stock News Headlines

April 13, 2024 | americanbankingnews.com
Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com
April 3, 2024 | finance.yahoo.com
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation
April 19, 2024 | DTI (Ad)
Special FREE offer on stock hotsheets
These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?
April 3, 2024 | prnewswire.com
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation
March 27, 2024 | investorplace.com
AMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023
March 26, 2024 | money.usnews.com
Ampio Pharmaceuticals Inc
March 26, 2024 | finanznachrichten.de
Ampio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC Deregistration
March 26, 2024 | msn.com
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings
April 19, 2024 | DTI (Ad)
Special FREE offer on stock hotsheets
These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?
March 25, 2024 | finance.yahoo.com
Ampio Announces Voluntary Delisting and SEC Deregistration
February 29, 2024 | msn.com
Ampio Pharmaceuticals, Ironwood, Incannex among healthcare movers
February 15, 2024 | finanznachrichten.de
Ampio Pharmaceuticals, Inc.: Ampio Provides Update on Results from Pre-IND Enabling Studies
February 14, 2024 | prnewswire.com
Ampio Provides Update on Results from Pre-IND Enabling Studies
January 26, 2024 | msn.com
Ampio Pharmaceuticals Announces At-The-Market Stock Offering
December 28, 2023 | seekingalpha.com
Sociedad Quimica Y Minera de Chile, Altice USA, Cingulate among premarket gainers' pack
December 1, 2023 | msn.com
What's Going On With Ampio Pharmaceuticals Stock?
December 1, 2023 | msn.com
Redhill Biopharma, Ampio Pharmaceuticals among healthcare movers
November 30, 2023 | benzinga.com
Thinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Group
October 5, 2023 | finance.yahoo.com
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
October 4, 2023 | finance.yahoo.com
Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now
September 26, 2023 | finance.yahoo.com
Ampio Pharmaceuticals to Present at the Emerging Growth Conference
September 7, 2023 | thestreet.com
Ampio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary Endpoint
August 31, 2023 | seekingalpha.com
Ampio Pharmaceuticals announces 20-to-1 reverse stock split
August 31, 2023 | markets.businessinsider.com
Ampio Pharmaceuticals Board Approves Reverse Stock Split - Quick Facts
August 31, 2023 | finance.yahoo.com
Ampio Pharmaceuticals Announces Reverse Stock Split
August 3, 2023 | benzinga.com
Thinking about buying stock in Wavedancer, Urogen Pharma, Ampio Pharmaceuticals, Innoviz Technologies, or Rigetti Computing?
June 22, 2023 | msn.com
3 Biotech Stocks to Buy With Explosive Upside Potential
See More Headlines
Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2024
Today
4/19/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:AMPE
CUSIP
N/A
CIK
1411906
Web
ampiopharma.com
Phone
720-437-6500
Fax
720-437-6501
Employees
6
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($11.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,630,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-149.00%
Return on Assets
-103.79%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.41
Quick Ratio
2.41

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.06

Miscellaneous

Outstanding Shares
1,140,000
Free Float
1,098,000
Market Cap
$285,000.00
Optionable
No Data
Beta
1.95
10 Best Stocks to Own in 2024 Cover
10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Michael A. Martino (Age 67)
    CEO & Director
    Comp: $550k
  • Mr. Daniel G. Stokely CPA (Age 60)
    CFO, Corporate Secretary & Treasurer
    Comp: $338.31k
  • Dr. David Bar-Or M.D. (Age 75)
    Founder & Chairman of Scientific Advisory Board
    Comp: $145.6k
  • April Ramirez
    Clinical Trial Manager

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

AMPE Stock Analysis - Frequently Asked Questions

How have AMPE shares performed in 2024?

Ampio Pharmaceuticals' stock was trading at $2.05 at the start of the year. Since then, AMPE stock has decreased by 82.9% and is now trading at $0.35.
View the best growth stocks for 2024 here.

When is Ampio Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our AMPE earnings forecast.

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) released its quarterly earnings data on Wednesday, March, 27th. The company reported ($2.48) EPS for the quarter.

When did Ampio Pharmaceuticals' stock split?

Ampio Pharmaceuticals's stock reverse split on the morning of Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL).

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AMPE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research